2024年美国肝病学会年会（AASLD 2024）于11月15日-19日在美国圣地亚哥盛大召开，本次大会上公布了多项慢性乙型病毒性肝炎（chronic hepatitis B ...

诸多研究表明，HBV疫苗接种后有较高的免疫应答效果，且安全性也得到证实，虽然我国在HBV的防治和乙肝的诊断与治疗方面取得了显著进展。但现有研究表明我国乙肝疫苗接种率依旧较低，仅约10%－20%，探究影响我国居民乙肝疫苗接种意愿的因素依然十分重要，对人 ...

Any person who might have a new sexual partner or use injection drugs is particularly recommended to get the hepatitis B ...

乙型肝炎（乙肝）病毒（Hepatitis B ...

I would like to know your opinion on the hepatitis B vaccine and its pros and cons. I'm a 39-year-old man who is thinking about potentially getting one.

The potency of GIGA-2339 is claimed to be more than 2,000 times greater than that of plasma-derived HBV treatments.

我国肝细胞癌（hepatocellular carcinoma, HCC）发生的主要原因是乙型肝炎病毒（hepatitis B virus, ...

Epigenic Therapeutics, a leading biotechnology company dedicated to developing next-generation gene modulation therapy, today announced that it has received approval of clinical trial application (CTA ...

New data has revealed less than one third of Victorians living with hepatitis B are receiving lifesaving follow-up care.

New data from Barinthus Bio's HBV003 trial has demonstrated durable HBsAG loss in participants with chronic hepatitis B.